Your session is about to expire
← Back to Search
Behavioural Intervention
Exercise Intervention for Brain Health
N/A
Recruiting
Led By Pamela G. Bowen, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Are between the ages of 35-65 years old
Diagnosed with hypertension
Must not have
Do not have hypertension
Unable to pass the fitness evaluation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests how exercise affects brain health, blood pressure, and eye vessels in people with high blood pressure and BMI.
Who is the study for?
This trial is for individuals aged 35-65 with hypertension and a BMI of at least 25 kg/m2. Participants must have a smartphone capable of installing two workout tracking apps and pass a fitness evaluation. Those over 300 lbs or without hypertension, as well as those who fail the fitness test or have a BMI under 25, cannot join.
What is being tested?
The study examines how moderate versus intensive exercise affects brain health over ten weeks. It looks at changes in brain health scores, blood pressure reduction, and eye blood vessel count in overweight patients with high blood pressure.
What are the potential side effects?
While not drug-related, side effects from increased physical activity could include muscle soreness, fatigue, joint pain, or injury. The intensity of these side effects may vary based on individual fitness levels and the type of exercise performed.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 35 and 65 years old.
Select...
I have been diagnosed with high blood pressure.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have high blood pressure.
Select...
I did not pass the fitness evaluation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Improved overall Brain Care Score metric.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Moderate Intensity Training (MIT) exercise groupExperimental Treatment1 Intervention
Participants will be asked to exercise independently 4 days/week for 10 weeks, following a moderate intensity training (MIT) protocol.
Group II: High Intensity Interval Training (HIIT) exercise group,Experimental Treatment1 Intervention
Participants will be asked to exercise independently 4 days/week for 10 weeks, following a high intensity interval training (HIIT) protocol.
Group III: Control exercise groupActive Control1 Intervention
Participants will be advised to follow the American Heart Association (AHA) guidelines on exercise.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,655 Previous Clinical Trials
2,444,120 Total Patients Enrolled
Pamela G. Bowen, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham